ADVM:Adverum Biotechnologies Inc - Stock Price Quote and Dividend Data

ADVM STOCK PRICE LATEST CLOSE

$3.40

EXCHANGE

NASDAQ

ADVM

Adverum Biotechnologies Inc Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Stock Split Date & FactorMar. 21, 2024 & 10.0000
Split Payment TypeReverse Split
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
ADVM

Adverum Biotechnologies Inc Stock Price Information

ADVM Stock Price Latest Close$3.40
52-Week Low/High Stock Price$3.32 - $12.72
Percent Held by Institutions17.69%
Revenue$2,000,000
Net Income$-121,245,000
Cash Flow$-106,665,000
EPS-1.30%
Market Cap$70,726,800
Issue TypeCommon, ordinary, ADR, etc.
PE Ratio0
PE Ratio to Industry114%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-72.97%
Total Return Last 3 Years-72.13%
Total Return Last 5 Years-96.83%
Latest Trade DateApr. 08, 2025
ADVM

Adverum Biotechnologies Inc Annual Stock Dividends

No Data available for Payment History.

ADVM

Adverum Biotechnologies Inc Dividend Payment History

No dividends retrieved for ADVM
ADVM

Adverum Biotechnologies Inc Other Dividend Details

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. Co. discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) IVT injections.

Web Sitewww.adverum.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Adverum Biotechnologies Inc Dividend Stock News and Updates

Apr. 03, 2025ADVM STOCK PRICE INCREASE: Adverum Biotechnologies Inc on 04-03-2025 increased stock price > 10% from $3.83 to $4.26

Apr. 02, 2025ADVM STOCK PRICE DECREASE: Adverum Biotechnologies Inc on 04-02-2025 decreased stock price > 10% from $4.37 to $3.83

Mar. 20, 2025ADVM STOCK PRICE INCREASE: Adverum Biotechnologies Inc on 03-20-2025 increased stock price > 10% from $4.90 to $5.41

Mar. 04, 2025ADVM STOCK PRICE DECREASE: Adverum Biotechnologies Inc on 03-04-2025 decreased stock price > 10% from $4.71 to $4.16

Jul. 20, 2024ADVM STOCK PRICE DECREASE: Adverum Biotechnologies Inc on 07-20-2024 decreased stock price > 10% from $9.48 to $8.17

Jun. 19, 2024ADVM STOCK PRICE 52 WEEK LOW: Adverum Biotechnologies Inc on 06-19-2024 hit a 52 week low of $6.59

Mar. 22, 2024ADVM STOCK PRICE INCREASE: Adverum Biotechnologies Inc on 03-22-2024 increased stock price > 10% from $1.52 to $14.75

More Adverum Biotechnologies Inc Dividend News
Biotechnology Dividend Stock News and Updates

Apr. 09, 2025TCBPY STOCK PRICE DECREASE: TC BioPharm (Holdings) plc on 04-09-2025 decreased stock price > 10% from $0.40 to $0.27

Apr. 09, 2025MAZE STOCK PRICE DECREASE: Maze Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $8.92 to $7.57

Apr. 09, 2025KANT STOCK PRICE DECREASE: Kineta Inc on 04-09-2025 decreased stock price > 10% from $0.35 to $0.30

Apr. 09, 2025ORKA STOCK PRICE DECREASE: Oruka Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $7.62 to $6.78

Apr. 09, 2025XCUR STOCK PRICE DECREASE: Com Par $0.0001/Exicure Inc on 04-09-2025 decreased stock price > 10% from $12.80 to $11.39

Apr. 09, 2025BIVI STOCK PRICE DECREASE: Cl A Par $0.0001/BioVie Inc on 04-09-2025 decreased stock price > 10% from $0.80 to $0.71

Apr. 09, 2025ARTV STOCK PRICE DECREASE: Artiva Biotherapeutics Inc on 04-09-2025 decreased stock price > 10% from $3.31 to $1.92

Apr. 09, 2025ENTO STOCK PRICE DECREASE: Com Par $0.0001 (New)/Entero Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.49 to $0.42

Apr. 09, 2025APDN STOCK PRICE DECREASE: Com Par $0.001 (New)/Applied DNA Sciences Inc on 04-09-2025 decreased stock price > 10% from $1.30 to $1.13

Apr. 09, 2025RKVTF STOCK PRICE DECREASE: Rakovina Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.06 to $0.05

More Biotechnology Dividend News
X
Search Dividend Investor